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ABSTRACT
Objectives: To: (1) determine the percentage of the
population in England that have access to a community
pharmacy within 20 min walk; (2) explore any
relationship between the walking distance and urbanity;
(3) explore any relationship between the walking
distance and social deprivation; and (4) explore any
interactions between urbanity, social deprivation and
community pharmacy access.
Design: This area level analysis spatial study used
postcodes for all community pharmacies in England.
Each postcode was assigned to a population lookup
table and lower super output area (LSOA). The LSOA
was then matched to urbanity (urban, town and fringe
or village, hamlet and isolated dwellings) and
deprivation decile (using the Index of Multiple
Deprivation score).
Primary outcome measure: Access to a community
pharmacy within 20 min walk.
Results: Overall, 89.2% of the population is estimated
to have access to a community pharmacy within
20 min walk. For urban areas, that is 98.3% of
the population, for town and fringe, 79.9% of the
population, while for rural areas, 18.9% of
the population. For areas of lowest deprivation
(deprivation decile 1) 90.2% of the population have
access to a community pharmacy within 20 min walk,
compared to 99.8% in areas of highest deprivation
(deprivation decile 10), a percentage difference of
9.6% (8.2, 10.9).
Conclusions: Our study shows that the majority of
the population can access a community pharmacy
within 20 min walk and crucially, access is greater in
areas of highest deprivation—a positive pharmacy care
law. More research is needed to explore the
perceptions and experiences of people—from various
levels of deprivation—around the accessibility of
community pharmacy services.
BACKGROUND
The role of the community pharmacist has
undergone rapid expansion in recent years
with a significant emphasis now placed on
delivering patient-focused services, including
promoting healthy lifestyles and modification
of health-related behaviours, as well as pro-
viding medicine-related activities.1 2 This
change has been acknowledged in England
through the National Health Service (NHS)
contractual framework for community phar-
macy, which has three distinct levels of
service: essential, advanced and locally
commissioned.3 The essential and advanced
levels of service are provided by all commu-
nity pharmacies in England and include dis-
pensing medication and providing medicine
use reviews, while the locally commissioned
services are provided in response to needs of
the local population. As such, many commu-
nity pharmacies now offer services, commis-
sioned by local authorities according to
need, which are designed to help address
public health priorities including smoking,
Strengths and limitations of this study
▪ Our study is the first to systematically examine
whether there is an inverse care law in relation to
community pharmacies and the first to analyse
geographical access to services in England.
▪ A key strength of this study is that we examined
accessibility of community pharmacies by
walking distance; the cost of driving and using
public transport can be significant barriers to
travel and, as such, may not give a true account
of community pharmacy accessibility.
▪ A possible limitation is that a 20 min walk from
each community pharmacy was represented
using a straight-line distance from the central
point of each pharmacy’s postcode to create a
buffer. This assumes people walk in straight
lines while, in reality, people are constrained to
pathways that curve or are sometimes cut-off by
barriers.
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alcohol misuse and obesity.4 These issues were identified
by The Strategic Review of Health Inequalities in England
(the Marmot Review) as significant modifiable risk
factors for inequalities in morbidity and mortality in
England.5 6 It is clear from the Marmot Review and
other research that the way in which society is organised
causes inequalities in these conditions, and inequalities
in these conditions are, in turn, major contributions to
overall inequalities in health, morbidity and mortality.
Significantly, more people die from these conditions in
disadvantaged areas compared to more affluent ones.7–9
Access to healthcare services is a well-established social
determinant of health: disadvantaged areas often lack
access to the level of NHS services that their health
needs require (such as primary care services). This has
been termed as an Inverse Care Law, as proposed by
Tudor Hart in 1971, who stated “the availability of good
medical care tends to vary inversely with the need for it
in the population served”.10
Rural areas are often disadvantaged in accessing
healthcare services such as general practitioner (GP)
practices. Previous studies show that a ‘distance decay’
effect operates in accessing healthcare services in rural
areas, with GP consultation rates declining as the dis-
tance from the GP surgery increases.11–13 There is a
common perception that people in rural areas are more
affluent and therefore healthier than their urban coun-
terparts, with a greater ability to adapt to and access
increasingly urbanised health services.14 15 For the older
population, who tend to have greater healthcare needs
accessing healthcare services may not be so easy, particu-
larly those in rural areas where there may be a lack of
suitable transport.16
Community pharmacies have, to date, been over-
looked in discussions around access to care, even
though they could potentially make a significant contri-
bution to this issue as there are over 12 000 community
pharmacies in England, distributed across urban/rural
and deprived/affluent areas. Estimates vary with regard
to the reach of this community pharmacy network, but
some sources suggest over 90% of the population makes
at least one visit to the pharmacy per year.17 18 Evidence
also suggests that a range of patients—of varying age,
gender and social class—visit community pharmacies
every month to collect prescriptions, purchase
over-the-counter medicine and obtain general health-
care advice.19 Community pharmacies therefore appear
to be uniquely placed to deliver healthcare initiatives
and can also be accessed without the patient needing a
prior appointment. This accessibility has consistently
improved in recent years with policy drivers to improve
access to medicines—including the promotion of ‘self-
care’—with the introduction of ‘100 hour pharmacies’,
which must open 100 h per week, for every week of the
year. However, it is not understood if community phar-
macies offer easy and equitable access to healthcare and
therefore contribute to, or ameliorate, the inverse care
law. Clearly, as with other healthcare services, for
community pharmacy services to be successful and to
contribute to reducing inequalities in health, it is vital
for these services to be available to the areas and patient
populations that need them most. This study, therefore,
aims to: (1) determine the percentage of the population
in England that have access to a community pharmacy
within 20 min walk; (2) explore any relationship
between the walking distance (the accessibility) and
urbanity; (3) explore any relationship between the
walking distance and social deprivation and (4) explore
any interactions between urbanity, social deprivation and
pharmacy access. The study is the first to examine
whether there is an inverse care law in relation to com-
munity pharmacies and the first to analyse geographical
access to services in England.
METHODS
Study design
This study explores the relationship between spatial
access to community pharmacies, deprivation and urban-
ity using geographical information systems and generali-
sed linear models.
Outcome
The percentage of the population that had access to a
community pharmacy within a 20 min walk by lower
super output area (LSOA): measured as a straight line
distance from each pharmacy (1.6 km buffers) and
aggregating the population by postcode within each
buffer compared to the LSOA population.
Definitions
Community pharmacy: Registered with the General
Pharmaceutical Council as premises for the compound-
ing, procurement, storage and distribution of medicines
and appliances; we excluded premises that were solely
registered as Internet pharmacies in the analysis.
LSOA: Geographic areas in England comprising of
approximately 1500 residents and 650 households. They
are designed to be of a reasonably compact shape while
being representative of social homogeneity.20
Urban/rural Ccassification: Categorises each LSOA into
three settlement types: urban (where the population is
over 10 000 people), town and fringe (part of a settle-
ment with less than 10 000 people) or village, hamlet
and isolated dwellings.21
Deprivation decile: The term ‘deprivation decile’ is used
to group the population into 10 equally spaced ordinal
categories according to a particular level of deprivation.
Data and variables
Data were obtained from the Fuse Geo-HealthCare
Database. This database contains data on the address and
postcode of each community pharmacy in England
(obtained from the General Pharmaceutical Council—
the independent regulator for pharmacists, pharmacy
technicians and pharmacy premises in Great Britain)22;
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the postcode of each community pharmacy (matched to
their corresponding coordinates using the Office of
National Statistics postcode directory, 2012)23; the coor-
dinates for each postcode in England (also from the
Office of National Statistics postcode directory, 2012—
matched to a population lookup table and the LSOA for
each postcode); whether the LSOA is urban (where the
population is over 10 000 people), town and fringe (part
of a settlement with less than 10 000 people) or village,
hamlet and isolated dwellings from the urban/rural clas-
sification (2005)21 and the Index of Multiple
Deprivation score (2010) for each LSOA (from the
Office of National Statistics).24 More details on the Fuse
Geo-HealthCare Database are available here: https://www.
dur.ac.uk/wolfson.institute/geohealth/
Analysis
The community pharmacy postcodes for England were
mapped using ArcMap. The average person walks 1 mile
(1.6 km) in 20 min,25 therefore 1.6 Km buffers were
placed around each pharmacy to represent a 20 min
walk from a community pharmacy. The population post-
codes were then clipped to the pharmacy buffers. Data
on the sum of the population for each LSOA overall and
within each community pharmacy buffer was extracted
by LSOA. The percentage of the population with access
to a pharmacy within 20 min walk was then calculated by
LSOA. Whether or not the LSOA was urban, town and
fringe or rural and the corresponding deprivation score
was attached to the data file. Deprivation deciles were
also calculated. The most deprived decile (10) equates
to the most deprived 10% within a population, while the
least deprived decile (1) represents the 10% of a popula-
tion living in the least deprived circumstances. Each data
set was then mapped using Arc GIS. Tables were pro-
duced to show the percentage of the population who
had access to a pharmacy within 20 min walk by depriv-
ation decile and by urban/rural classification within the
deprivation deciles. Generalised linear models were
used to adjust for rurality within each deprivation decile
to produce urban/rural adjusted prevalence rates of the
percentage of households with access to a pharmacy
within 20 min walk by LSOA and the results tabulated.
RESULTS
Urban rural/deprivation decile access
Data for all of the LSOAs in England shows that 89.2%
of the population has access to a community pharmacy
within 20 min walk. In total 98.3% of the households in
the urban areas are estimated to have access to a phar-
macy within 20 min walk. In town and fringe, the per-
centage of households that have access to a community
pharmacy is estimated as 79.9% while the percentage of
those in the rural areas is estimated as 18.9%.
The distributions of percentages of households with
access to a community pharmacy within 20 min are pre-
sented in table 1 (and shown spatially in figures 1 and 2)
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according to their deprivation decile and urban, town
and fringe and rural areas. There is a significant non-
linear association between the deprivation deciles
(a u-shaped access curve, see figure 3): the least deprived
and most deprived households have more access to a
pharmacy than the households in the middle of the
deprivation range. Overall, the inequalities in access to
pharmacies in England range between 0.3% less and
20.2% less access when compared to the most deprived
areas. There are higher spatial inequalities in access in
rural areas with ranges of 6.7–30.4% less access in com-
parison to 3.5–26.2% for town and fringe, and 0.1–3.7%
for urban areas—spatial inequalities in access are thus
much smaller in urban areas.
Urban areas have the least difference between the
most and least deprived LSOAs with only 3.7% less of
the population having access to a pharmacy within
20 min’ walk in the least deprived LSOAs. In town and
fringe LSOAs this rose to 17.9% difference, while in
rural areas there was no significant difference between
the least and most deprived LSOAs.
Overall, there is a clear dose—response relationship
between access to community pharmacies and urbanity
levels. Specifically, the urban areas have more access to
community pharmacies, followed by town/fringe while
the rural areas have the least access to pharmacies—
regardless of deprivation.
After controlling for the effects of rurality, only two
deprivation deciles have marginally below 95% of the
population being able to walk to a community pharmacy
within 20 min.
DISCUSSION
Principal findings of this study
The data has shown that 89% of the population in
England has access to a community pharmacy within
20 min walk. Crucially, there is a positive trend between
community pharmacy accessibility and deprivation
decile—with the highest access in the most deprived
areas—showing there is no inverse pharmacy law for
community pharmacy distribution in England. Indeed
Figure 1 Map of England with LSOA stratified according to deprivation.
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we have found evidence of a positive pharmacy care law.
Populations in urban areas of England also have better
access to a community pharmacy, compared to popula-
tions in town and fringe and rural areas.
Strengths and weaknesses
This study sought to explore the accessibility of commu-
nity pharmacies in England by walking distance: this is a
key strength. We deliberately did not seek to explore
accessibility by car or by using public transport, as we feel
this would not give a true picture of accessibility for
patients living in more deprived areas. Indeed, as access
to a car is linked to income—with households in under-
privileged areas having less access26—it is conceivable
that this may be more of a significant barrier for patients
living in deprived areas if the pharmacy was only accessi-
ble by driving; similarly, for public transport, the cost of
using such services may prove to be a barrier to
Figure 2 Map of England showing the population within 20 minutes walk of a community pharmacy.
Figure 3 Percentage of the
population with access to a
pharmacy within 20 min’ walk by
deprivation decile before and after
adjusting for Urbanity.
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households with low incomes.27 In terms of study limita-
tions, while we believe our results are robust and have
important implications for the commissioning of health-
care services from community pharmacy settings, we
acknowledge that, in the analysis, we did not consider the
individual services offered from each community phar-
macy, which may show some local variability due to
current commissioning systems. We also acknowledge
that our work only explores accessibility from a geograph-
ical viewpoint and not a social perspective. Indeed, just
because a community pharmacy offers a healthcare
service and is within walking distance of a particular
household does not necessarily mean that people per-
ceive them as valuable or would be willing to access the
service. A study exploring the perceptions and experi-
ences of people—from various levels of deprivation—
around the accessibility of community pharmacy services
is therefore warranted. In terms of a methodological view-
point, we recognise a 20-min walk from each community
pharmacy was represented using a straight-line distance
from the central point of each pharmacy’s postcode to
create a buffer. This assumes people are able to walk in
any direction from that postcode and always in a straight
line. In reality people are constrained to pathways that
may curve, or even be cut off by barriers. A further limita-
tion is that of the postcodes themselves. An individual
postcode represents an average of 15 addresses, with the
coordinates of each postcode being represented using
the geographic centroid of each postcode. Particularly in
rural areas, where houses are more sparsely spread, this
could ostensibly mean that some households will fall
outside of a pharmacy buffer, when in fact this is not the
case for some addresses. Equally, however, some
addresses will fall inside a buffer, so, over a large popula-
tion, one would expect this issue to even out.
What is already known?
There have been several mapping studies published
exploring the distribution and accessibility of community
pharmacies in areas of America and Canada. For
example, a study by Lin (2004) explored the accessibility
of community pharmacies by elderly patients in Illinois
and sought to estimate the disparity between urban and
rural areas. The study found that, on average, there were
1.27 and 0.38 pharmacies per 10 000 people in urban
and rural areas, respectively. In terms of accessibility, the
average distance for an elderly patient was 0.9 miles in
urban areas but significantly higher at 5.9 miles in rural
areas.28 While Law et al,29 examined the geographical
access to community pharmacies in Ontario and found
over 60% of the population reside within walking dis-
tance of at least one community pharmacy. Our original
work shows geographical accessibility is even higher in
England. Despite studies published concerning commu-
nity pharmacies in America and Canada, there has been
no study published in the literature that has explored
accessibility of community pharmacies in England. The
recent White Paper Pharmacy in England: Building on
Strengths—delivering the future, published by the
Department of Health in 2008, claimed that, in
England, 99% of the population can get to a pharmacy
within 20 min by car and 96% by walking or using
public transport.2 However, while our report supports
this finding to some extent, it was not clear which meth-
odological approach was used to obtain this result, as, to
the authors knowledge, no supporting data were pub-
lished outlining methodology; and—crucially—the
Department of Health report did not assess how varying
levels of social deprivation influence the accessibility to
a community pharmacy. In addition, since the publica-
tion of the White Paper and report, many more commu-
nity pharmacies have since been opened in England.
Opening a new community pharmacy can be a complex
process, as new applications made to NHS England are
assessed against a Pharmaceutical Needs Assessment for
a particular area30—with areas of the most need having
a higher probability of a new application being granted.
It is, however, unlikely that the control of entry criteria
can fully explain our findings in relation to community
pharmacy distribution, as these regulations change over
time and often have exemptions (eg, up until recently
100 h community pharmacies were exempt from the
criteria).
Previous research has shown that healthcare interven-
tions delivered by community pharmacies are accessible.
By way of example, several small-scale studies have com-
pared accessibility of emergency hormonal contracep-
tion (EHC) from a community pharmacy setting to
other healthcare providers. These studies have shown that
women who went to a community pharmacy had more
rapid access to EHC, compared to other settings, such as
family planning clinics.31 32 Given that the effectiveness of
EHC is related to how quickly it is taken after unprotected
sexual intercourse this may prove to have a significant
clinical benefit. Other studies, rather than explore accessi-
bility as such, have used community pharmacies to target
healthcare interventions towards ‘hard to reach’ areas. For
example, Murphy et al,33 showed community pharmacies
are convenient and accessible, and can provide influenza
vaccination programmes in medically underserved com-
munities, while Kellow34 successfully delivered a commu-
nity pharmacy weight management programme to young
adults in a rural setting. These studies demonstrate the
potential for community pharmacies to deliver healthcare
interventions to areas of the greatest need.
Implications for policymakers
This is the first study to systematically explore the spatial
distribution of community pharmacies in England. It is
also the first study that examines the relationship
between accessibility of community pharmacies and
social deprivation and to explore the idea of an inverse
pharmacy care law. The paper shows that community phar-
macies are easily accessible by the majority of the popu-
lation in England, with 89% able access a community
pharmacy within 20 min walk. Our study also shows that
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there is no inverse pharmacy law for community phar-
macies in England: access to a community pharmacy is
greater in areas of higher deprivation compared to
more affluent areas—a positive pharmacy care law. This is a
very timely finding as a recent initiative led by NHS
England—the Call to Action—is seeking to develop local
strategy for community pharmacy initiatives and inform
strategic policy making in terms of commissioning com-
munity pharmacy services.35 Our work supports this initia-
tive and shows that community pharmacies are uniquely
placed in the community to deliver healthcare interven-
tions. In addition, as the accessibility of community phar-
macies is greatest in areas of highest deprivation, they
may have an important role to play in reducing inequal-
ities in priority public health conditions in England.
CONCLUSIONS
Community pharmacies have the potential to offer con-
venient and equitable access to healthcare. The vast
majority of households in England—and especially
those in the most deprived areas—have access to a com-
munity pharmacy within 20 min walk: a positive phar-
macy care law. This potentially has major implications
for the commissioning of future services from commu-
nity pharmacies in England.
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